---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-108617"
form_type: "8-K"
ticker: "CPHI"
cik: "0001106644"
company_name: "CHINA PHARMA HOLDINGS, INC."
filed_at: "2024-12-13T23:59:59+00:00"
generated_at: "2026-05-29T03:20:12.580979+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# China Pharma enters into up to $600,000 at-the-market equity offering with institutional investor

## Summary
- SPA signed Dec 12, 2024 for up to $600K of common stock at market price, floor $0.15.
- Commitment period Dec 12 – Dec 31, 2024; investor has sole discretion to purchase.
- Pricing: lower of prior day close or 5-day avg; repricing if delivery delayed; MFN clause for 30 days.
- Investor may return shares within one business day for any reason; no minimum offering amount.
- Shares issued under existing S-3 shelf (File 333-276481); proceeds not determinable.

## SEC filing metadata
- accession: 0001213900-24-108617
- form_type: 8-K
- ticker: CPHI
- cik: 0001106644
- company_name: CHINA PHARMA HOLDINGS, INC.
- filed_at: 2024-12-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1106644/000121390024108617/0001213900-24-108617-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1106644/000121390024108617/ea0224537-8k_china.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-108617
- JSON: https://secwatch.observer/filing/0001213900-24-108617.json
- Plain text: https://secwatch.observer/filing/0001213900-24-108617.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.